Activity of alemtuzumab in patients with CD52-positive acute leukemia

Raoul Tibes, Michael J. Keating, Alessandra Ferrajoli, William Wierda, Farhad Ravandi, Guillermo Garcia-Manero, Susan O'Brien, Jorge Cortes, Srdan Verstovsek, Mary L. Browning, Stefan Faderl

Research output: Contribution to journal › Article › peer-review

82 Scopus citations

Fingerprint

Dive into the research topics of 'Activity of alemtuzumab in patients with CD52-positive acute leukemia'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science